TGF β 3 Antibodies

Santa Cruz Biotechnology delivers a wide array of TGF β 3 monoclonal antibodies for research focused on understanding cellular regulation and development. TGF β 3 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Transforming Growth Factor Beta 3 (TGF β 3) functions as a key regulator in cellular processes such as proliferation, differentiation, and immune response. TGF β 3 plays a significant role in tissue repair and fibrosis, making it an important target for studies related to wound healing and various diseases. Understanding TGF β 3 mechanisms has become essential for developing therapeutic strategies in conditions like cancer and autoimmune disorders. Research has shown TGF β 3's involvement in embryonic development, particularly in palate fusion and cardiac formation. Recent studies have highlighted TGF β 3's potential as a therapeutic target in treating fibrotic diseases and promoting wound healing. Ongoing investigations continue to reveal new functions of TGF β 3 in different physiological and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of TGF β 3's role in health and disease.